Search all content on GOV.UK

How to get information including patient information leaflets (PILs), details on how the medicine can be used (SmPCs) and scientific reports (PARs).

• Updated: 19 December 2019

Information on carrying medicine containing controlled drugs for individual travellers entering or leaving the UK.

• Updated: 11 April 2023

• Updated: 3 December 2020

Potential effects on performance of prescription and or over the counter drugs.

• Updated: 28 October 2005

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved the medicine aprocitentan (Jeraygo) to treat hypertension (high blood pressure) in adults whose blood pressure cannot be adequately controlled by at least three other medicines (also known as resistant hypertension).

• Updated: 17 January 2025

How the MHRA makes decisions on what is a medicinal product (borderline products).

• Updated: 8 January 2024

Information for patients, healthcare professionals and developers of new medicines

• Updated: 10 August 2022

Pharmacy (P), prescription-only (POM), and general sale list (GSL) medicines: apply to move your medicine to a different classification.

• Updated: 20 February 2025

How to register with an NHS doctor and patient questionnaires in Ukrainian and Russian.

• Updated: 16 January 2023

As a vet or pharmacist, you must follow legal requirements when working with controlled drugs in veterinary medicine.

• Updated: 17 May 2024